Cambridge Biotech Corp.ora- Ti

Basic Information

365 Plantation Street
Worcester, MA, 01605

Company Profile

n/a

Additional Details

Field Value
DUNS: n/a
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: n/a


  1. RAPID DIAGNOSTIC FOR CLOSTRIDIUM DIFFICILE TOXIN B

    Amount: $515,460.00

    THE LONG-TERM OBJECTIVE IS TO DEVELOP A RAPID ENZYME LINKED IMMUNOASSAY FOR TOXIGENIC CLOSTRIDIUM DIFFICILE. C. DIFFICILE IS THE MOST FREQUENT CAUSE OF ANTIBIOTIC-ASSOCIATED DIARRHEA AND COLITIS, AND ...

    SBIR Phase II 1994 Department of Health and Human Services
  2. RECOMBINANT SUBUNIT VACCINE FOR HUMAN CYTOMEGALOVIRUS

    Amount: $7,230.00

    THE LONG-TERM OBJECTIVE OF THIS PROJECT IS THE DEVELOPMENT OF AN EFFECTIVE VACCINE AGAINST HUMAN CYTOMEGALOVIRUS (CMV). TO ACCOMPLISH THIS, EXPERIMENTAL FORMULATIONS CONTAINING A UNIQUE AND SAFE PURIF ...

    SBIR Phase I 1991 Department of Health and Human Services
  3. RAPID DIAGNOSTIC FOR CLOSTRIDIUM DIFFICILE TOXIN B

    Amount: $50,000.00

    N/A

    SBIR Phase I 1991 Department of Health and Human Services
  4. PURIFICATION OF HTLV-I RECOMBINANT ENVELOPE ANTIGEN

    Amount: $429,624.00

    THE LONG TERM OBJECTIVE OF THE RESEARCH INITIATED BY THIS PROPOSAL IS TO DEVELOP AN IMPROVED DIAGNOSTIC ASSAY FOR DETECTION OF ANTIBODIES TO HTLV-I IN HUMAN SERA USING RECOMBINANT DNA DERIVED ANTIGENS ...

    SBIR Phase II 1989 Department of Health and Human Services
  5. PURIFICATION OF HTLV-I RECOMBINANT ENVELOPE ANTIGEN

    Amount: $50,000.00

    N/A

    SBIR Phase I 1988 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government